|Table of Contents|

Evaluation of tools for predicting chemotherapeutic toxicity in elderly cancer patients

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2024 22
Page:
4401-4404
Research Field:
Publishing date:

Info

Title:
Evaluation of tools for predicting chemotherapeutic toxicity in elderly cancer patients
Author(s):
FU Yucui; JIANG Qiuying
Department of Medical Oncology,the Second Affiliated Hospital of Harbin Medical University,Heilongjiang Harbin 150086,China．
Keywords:
elderly patients; chemotherapy toxicity; predicting tool
PACS:
R730.5
DOI:
10.3969/j.issn.1672-4992.2024.22.032
Abstract:
With the aging of the population,the number of elderly patients with cancer is increasing.The physical function of elderly tumor patients is decreased,and they are easy to combine with various diseases,which makes them have obvious adverse reactions and increased risk of chemotherapy,and chemotherapy is limited.However,the current clinical trials are underrepresented in elderly patients,and copying the guidelines may be detrimental to elderly patients.However,if carefully selected and monitored,some elderly patients can avoid the serious toxicity of chemotherapy,and some can also benefit from chemotherapy.This article reviews the tools used to predict the toxicity of chemotherapy in elderly patients with cancer,in order to help clinicians choose the best tool.

References:

［1］ 庞国防,胡才友,杨泽.中国人口老龄化趋势与对策［J］.中国老年保健医学,2021,19(01):3-5. PANG GF,HU CY,YANG Z.China's population aging trend and countermeasures 2020［J］.Chinese Journal of Geriatrics,2021,19(01):3-5.
［2］ 王文翔,段远琼,尹如铁.2023 NCCN临床实践指南：老年肿瘤（第一版）解读［J］.肿瘤学杂志,2024,30(02):157-161. WANG WX,DUAN YQ,YIN RT.Interpretation of the NCCN guidelines for older adult oncology version 1.2023［J］.Journal of Chinese Oncology,2024,30(02):157-161.
［3］LICHTMAN SM,WILDIERS H,CHATELUT E,et al.International society of geriatric oncology chemotherapy taskforce:evaluation of chemotherapy in older patients-an analysis of the medical literature［J］.J Clin Oncol,2007,25(14):1832-1843.
［4］贾延睿.老年综合功能评估系统（CGA）在老年恶性肿瘤化疗中的应用研究［D］.济南：山东大学,2016. JIA YR.The research of Comprehensive Geriatric Assessment (CGA) in elderly cancer patients for chemotherapy［D］.Jinan:Shandong University,2016.
［5］ALMODOVAR T,TEIXEIRA E,BARROSO A,et al.Elderly patients with advanced NSCLC:The value of geriatric evaluation and the feasibility of CGA alternatives in predicting chemotherapy toxicity［J］.Pulmonology,2019,25(1):40-50.
［6］MARTINE EM,IVETTE B,RICHARD R,et al.Predicting the risk of chemotherapy toxicity in older patients:The Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score［J］.Cancer,2012,118(13):3377-3386.
［7］ HURRIA A,MOHILE S,GAJRA A,et al.Validation of a prediction tool for chemotherapy toxicity in older adults with cancer［J］.J Clin Oncol,2016,34(20):2366-2371.
［8］ HURRIA A,TOGAWA K,MOHILE SG,et al.Predicting chemotherapy toxicity in older adults with cancer:A prospective multicenter study［J］.J Clin Oncol,2011,29(25):3457-3465.
［9］ MARINELLO R,MARENCO D,ROGLIA D,et al.Predictors of treatment failures during chemotherapy:A prospective study on 110 older cancer patients［J］.Arch Gerontol Geriatr,2009,48(2):222-226.
［10］ORTLAND I,MENDEL OM,KOWAR M,et al.Comparing the performance of the CARG and the CRASH score for predicting toxicity in older patients with cancer［J］.J Geriatr Oncol,2020,11(6):997-1005.
［11］LUND CM,VISTISEN KK,DEHLENDORFF C,et al.The effect of geriatric intervention in frail elderly patients receiving chemotherapy for colorectal cancer:a randomized trial (GERICO)［J］.BMC Cancer,2017,17(1):448.
［12］ MOTH EB,KIELY BE,STEFANIC N,et al.Predicting chemotherapy toxicity in older adults:comparing the predictive value of the CARG toxicity score with oncologists' estimates of toxicity based on clinical judgement［J］.J Geriatr Oncol,2019,10(2):202-209.
［13］ ALIBHAI SM,AZIZ S,MANOKUMAR T,et al.A comparison of the CARG tool,the VES-13,and oncologist judgment in predicting grade 3+toxicities in men undergoing chemotherapy for metastatic prostate cancer［J］.J Geriatr Oncol,2017,8(1):31-36.
［14］ ALBAIN KS,CROWLEY JJ,LEBLANC M,et al.Survival determinants in extensive-stage non-small-cell lung cancer:the Southwest Oncology Group experience［J］.J Clin Oncol,1991,9(9):1618-1626.
［15］ BAJORIN DF,DODD PM,MAZUMDAR M,et al.Long-term survival in metastatic transitionalcell carcinoma and prognostic factors predicting outcome of therapy［J］.J Clin Oncol,1999,17(10):3173-3181.
［16］MOTZER RJ,BACIK J,SCHWARTZ LH,et al.Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma［J］.J Clin Oncol,2004,22(3):454-463.
［17］SAKEENA R,JAMES LR,NADIA M,et al.Assessment of frailty and risk of chemotherapy toxicity at a geriatric-oncology multidisciplinary clinic［J］.R I Med J,2023,106(4):13-18.
［18］HURRIA A,WILDES T,BLAIR SL,et al.Senior adult oncology,version 2.2014:clinical practice guidelines in oncology［J］.J Natl Compr Canc Netw,2014,12(1):82-126.
［19］ KOTZERKE D,MORITZ F,MANTOVANI L,et al.The performance of three oncogeriatric screening tools-G8,optimised G8 and CARG-in predicting chemotherapy-related toxicity in older patients with cancer.A prospective clinical study［J］.J Geriatr Oncol,2019,10(6):937-943.
［20］ PILOTTO A,CELLA A,PILOTTO A,et al.Three decades of comprehensive geriatric assessment:evidence coming from different healthcare settings and specific clinical conditions［J］.J Am Med Dir Assoc,2017,18(2):191-192.
［21］CHAIBI P,MAGNE N,BRETON S,et al.Influence of geriatric consultation with comprehensive geriatric assessment on final therapeutic decision in elderly cancer patients［J］.Crit Rev Oncol Hematol,2011,79(3):302-307.
［22］ SANDRINE S,DELPHINE B,ZARA S,et al.Impact of the comprehensive geriatric assessment on treatment decision in geriatric oncology［J］.BMC Cancer,2020,20(1):384.
［23］ HAMAKER ME,JONKER JM,DE ROOIJ SE,et al.Frailty screening methods for predicting outcome of a comprehensive geriatric assessment in elderly patients with cancer:a systematic review［J］.Lancet Oncol,2012,13(10):e437-e444.
［24］HERNANDEZ TC,HSU T.Comprehensive geriatric assessment in the older adult with cancer:A review［J］.Eur Urol Focus,2017,3(4-5):330-339.
［25］ MOHILE SG,DALE W,SOMERFIELD MR,et al.Practical assessment and management of vulnerabilities in older patients receiving chemotherapy:ASCO guideline for geriatric oncology［J］.J Clin Oncol,2018,36(22):2326-2347.
［26］ YOSHIDA H,SHINTANI D,KAWASHIMA N,et al.Predicting toxicity of platinum and taxane-based chemotherapy in older patients with gynecologic cancer［J］.J BUON,2020,25(2):736-742.
［27］ ZHANG J,LIAO X,FENG J,et al.Prospective comparison of the value of CRASH and CARG toxicity scores in predicting chemotherapy toxicity in geriatric oncology［J］.Oncol Lett,2019,18(5):4947-4955.
［28］ CZAJKA S，TABOREK，KRZYCH LJ．Is frailty a good predictor of postoperative complications in elective abdominal surgery?-A single-center,prospective,observational study［J］.J Pers Med,2023,13(5):869．
［29］ CHAN WL,MA T,CHEUNG KL,et al.The predictive value of G8 and the cancer and aging research group chemotherapy toxicity tool in treatment-related toxicity in older Chinese patients with cancer［J］.J Geriatr Oncol,2021,12(4):557-562.
［30］ SOUBEYRAN P,BELLERA C,GOYARD J,et al.Screening for vulnerability in older cancer patients:the oncodage prospective multicenter cohort study［J］.PLoS One,2014,9(12):e115060.
［31］ BAITAR A,VAN FRAEYENHOVE F,VANDEBROEK A,et al.Evaluation of the groningen frailty indicator and the G8 questionnaire as screening tools for frailty in older patients with cancer［J］.J Geriatr Oncol,2013,4(1):32-38.
［32］ PALLIS AG,RING A,FORTPIED C,et al.Eortc workshop on clinical trial methodology in older individuals with a diagnosis of solid tumors［J］.Ann Oncol,2011,22(8):1922-1926.
［33］ MARTINEZ-TAPIA C,CANOUI-POITRINE F,BASTUJI-GARIN S,et al.Optimizing the G8 screening tool for older patients with cancer:diagnostic performance and validation of a six-item version［J］.Oncologist,2016,21(2):188-195.
［34］ MARTINEZ-TAPIA C,PAILLAUD E,LIUU E,et al.Prognostic value of the G8 and modifified-G8 screening tools for multidimensional health problems in older patients with cancer［J］.Eur J Cancer,2017,83:211-219.
［35］ PAMOUKDJIAN F,CANOUI-POITRINE F,LONGELIN-LOMBARD C,et al.Diagnostic performance of gait speed,G8 and G8 modifified indices to screen for vulnerability in older cancer patients:the prospective PF-EC cohort study［J］.Oncotarget,2017,8(31):50393-50402.
［36］SALIBA D,ORLANDO M,WENGER NS,et al.Identifying a short functional disability screen for older persons［J］.J Gerontol A Biol Sci Med Sci,2000,55(12):M750-M756.
［37］ OWUSUC,MARGEVICIUS S,SCHLUCHTER M,et al.Vulnerable elders survey and socioeconomic status predict functional decline and death among older women with newly diagnosed nonmetastatic breast cancer［J］.Cancer,2016,122(16):2579-2586.
［38］ SOUBEYRAN P,BELLERA C,GOYARD J,et al.Validation of the G8 screening tool in geriatric oncology:the ONCODAGE project［J］.J Clin Oncol,2011,29:9001.
［39］ MONFARDINI S,BASSO U,FIDUCCIA P,et al.Can the short screening test vulnerable elders survey 13 (VES-13) substitute for the time-consuming comprehensive geriatric assessment (CGA) to identify vulnerable/frail elderly breast cancer patients［J］.J Clin Oncol,2010,28:9114.
［40］FERRERO A,VILLA M,TRIPODI E,et al.Can vulnerable elders survey-13 predict the impact of frailty on chemotherapy in elderly patients with gynaecological malignancies［J］.Medicine,2018,97(39):e12298.
［41］ FRUH M,ROLLAND E,PIGNON JP,et al.Pooled analysis of the effect of age on adjuvant cisplatin-based chemotherapy for completely resected non-small-cell lung cancer［J］.J Clin Oncol,2008,26(21):3573-3581.
［42］MOTH EB,KIELY BE,STEFANIC N,et al.Oncologists' perceptions on the usefulness of geriatric assessment measures and the CARG toxicity score when prescribing chemotherapy for older patients with cancer［J］.J Geriatr Oncol,2019,10(2):210-215.

Memo

Memo:
-
Last Update: 1900-01-01